ArthroCare (ARTC) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ARTC Hot Sheet
Price: $10.01 -0.3%
Financial Fact:
Other income and expense: -1.13M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Other income and expense: -1.13M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
ArthroCare (NASDAQ: ARTC) reported Q1 EPS of $0.36, $0.02 better than the analyst estimate of $0.34. Revenue for the quarter came in at $92.9 million versus the consensus estimate of $88.21 million.
For earnings history and earnings-related data on ArthroCare (ARTC) click here.
For earnings history and earnings-related data on ArthroCare (ARTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
- Array Technologies Inc. (ARRY) Misses Q3 EPS by 3c ; Offers Guidance
- Myriad Genetics (MYGN) Tops Q3 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
